Summary
UnitedHealth Group's 2014 10-K filing highlights a company with diversified operations across health benefits (UnitedHealthcare) and health services (Optum). The report details significant revenue growth, driven by expansion in senior and public markets within UnitedHealthcare and strong performance across all Optum businesses, particularly OptumRx. Despite revenue growth, the company faced pressures from the Affordable Care Act (ACA) fees, Medicare Advantage funding reductions, and increased spending on specialty medications, which impacted earnings from operations for the UnitedHealthcare segment. Key financial highlights include a 7% increase in consolidated revenues to $130.5 billion, with Optum revenues growing 25%. Diluted earnings per share increased by 4% to $5.70. The company also continued its focus on returning capital to shareholders through dividends and share repurchases, while managing its balance sheet with a debt-to-debt-plus-equity ratio of 34.9%. The filing also notes significant investments in technology and clinical capabilities, positioning the company for future growth in an evolving healthcare landscape.
Financial Highlights
56 data points| Revenue | $130.47B |
| Cost of Revenue | $3.83B |
| Gross Profit | $126.65B |
| SG&A Expenses | $21.26B |
| Operating Expenses | $120.20B |
| Operating Income | $10.27B |
| Interest Expense | $618.00M |
| Net Income | $5.62B |
| EPS (Basic) | $5.78 |
| EPS (Diluted) | $5.70 |
| Shares Outstanding (Basic) | 972.00M |
| Shares Outstanding (Diluted) | 986.00M |
Key Highlights
- 1Consolidated revenues grew 7% to $130.47 billion, with Optum segment revenues showing robust growth of 25%.
- 2UnitedHealthcare's revenue increased by 5%, driven by growth in public and senior markets, though operating earnings in this segment decreased by 2% due to ACA fees and Medicare Advantage funding reductions.
- 3Optum's businesses demonstrated strong performance, with OptumHealth up 12%, OptumInsight up 11%, and OptumRx up 33% in revenue.
- 4Diluted earnings per share increased by 4% to $5.70, although the company noted a negative year-over-year impact of approximately $1.00 per share from ACA fees and other ACA-related impacts.
- 5The company returned $5.4 billion to shareholders in 2014 through $4.0 billion in share repurchases and $1.4 billion in dividends.
- 6As of December 31, 2014, UnitedHealth Group served approximately 45 million individuals across its UnitedHealthcare medical businesses.
- 7The company had $8.6 billion in its order backlog for OptumInsight, indicating future revenue streams from technology and consulting services.